Massive antitrust settlements last year and in 2020 were supposed to end a protracted legal battle for the Blue Cross and ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

Blue Cross Blue Shield was hit with six federal antitrust suits on the day of the deadline for health care provider class ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the ...

Elevance Health is in financially very healthy shape and is strongly profitable. Click here to read more on the analysis of ...

No heartbeat. No breathing. No pulse. But Amanda Boley’s insurance company said she still should have obtained preapproval.

The gloves were off even earlier than that after Canadian fans loudly booed the entirety of the U.S. national anthem ahead of the American's 3-1 win at the Bell Centre in Montreal. The tournament ...

Earnings per share (EPS) missed analyst estimates by 5.2%. The primary driver behind last 12 months revenue was the Health Benefits segment contributing a total revenue of US$150.3b (85% of total ...

Elevance Health experienced a rating downgrade from “buy” to “hold” by StockNews.com, reflecting a shift in analyst sentiment. Despite this, other analysts remain optimistic, with Cantor Fitzgerald ...

Elevance Health, Inc. (NYSE:ELV – Get Free Report) shares gapped down before the market opened on Friday . The stock had previously closed at $390.50, but opened at $379.00. Elevance Health ...

Operating under the Anthem Blue Cross and Blue Shield, Wellpoint ... Sarah James reaffirmed an “Overweight“ rating on Elevance Health with a $485 price target, citing its undervaluation ...